The company now expects organic net sales to be at the low end of the previous guidance range of down 2% to flat versus the prior year. The company also expects adjusted operating income growth to be at the low end of the previous guidance range of 1% to 3% versus the prior year. Abrams-Rivera continued, “While a recovery is taking longer than originally anticipated, we are not losing sight of our long-term strategy. We remain confident in our ability to drive profitable growth, generate strong cash flow, and return capital to our stockholders.”
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks